当前位置:首页 > 报告详情

Sarah Walker – 新型试验设计速览 v1.pdf

上传人: 芦苇 编号:1146355 2026-02-14 32页 1.16MB

1、A whistlestop tour of novel trial designsSarah WalkerProfessor of Medical Statistics&EpidemiologyParadigm of evidence-based medicine“One regimen to rule them all”“Standard of care”,SOC,“control”:simultaneously maximising good outcomes and minimising bad outcomes(toxicity)Recommended in guidelines,sh

2、ould be generally used in all/most patientsIteratively improve this“optimal regimen”through series of(generally two-arm)randomised controlled trials vs SOCLed to massive improvements in outcomes forTuberculosisCancer chemotherapyHIVInnovation“Platform”designs/master protocolsMulti-Arm Multi-Stage(MA

3、MS)Baskets UmbrellasFactorial Compare multiple new interventions vs SOC to iteratively improve SOC faster Maximise efficiency in trial operationsMAMS(Multi-Arm Multi-Stage)Multi-arm:Test many relevant agents within one protocolMulti-arm,Multi-stageT2T3T1CT4Phase IIPhase IIIMulti-arm,Multi-stageT2T3T

4、1CT4Phase IIPhase IIIMAMS(Multi-Arm Multi-Stage)Multi-arm:Test many relevant agents within one protocolMulti-stage:Ask if reasons to continue investigating a treatment?Stop arms early for lack of benefit(“pick the winners”)OR lack of sufficient activity(“drop the losers”)Based on an intermediate(sur

5、rogate)outcomeMulti-arm,Multi-stageT2T3T1CT4Phase IIPhase IIIMulti-arm,Multi-stageT2T3T1CT4Phase IIPhase IIIMAMS(Multi-Arm Multi-Stage)Multi-arm:Test many relevant agents within one protocolMulti-stage:Ask if reasons to continue investigating a treatment?Stop arms early for lack of benefit(“pick the

6、 winners”)OR lack of sufficient activity(“drop the losers”)Based on an intermediate(surrogate)outcomeMulti-arm,Multi-stageT2T3T1CT4Phase IIPhase IIIMulti-arm,Multi-stageT2T3T1CT4Phase IIPhase IIIOther types of platform trial Basket vs umbrella?Basket trials:same intervention evaluated on multiple di

word格式文档无特别注明外均可编辑修改,预览文件经过压缩,下载原文更清晰!
三个皮匠报告文库所有资源均是客户上传分享,仅供网友学习交流,未经上传用户书面授权,请勿作商用。
1. **传统试验设计的局限**:传统“标准治疗”(SOC)的两臂随机对照试验迭代优化效率低,难以快速提升疗效。 2. **平台试验创新**:包括多臂多阶段(MAMS)、篮子(Basket)、伞形(Umbrella)和析因(Factorial)设计,可同时测试多种干预措施,通过早期无效臂终止(“选优汰劣”)提升效率。 3. **MAMS-ROCI设计**:针对连续变量(如抗生素疗程),通过多臂试验估计“剂量-反应曲线”,直接确定非劣效或目标疗效的最优剂量(如PediCAP试验比较4-8天抗生素疗程)。 4. **PRACTical设计**:无统一SOC,患者根据个体情况随机化 subset 治疗(如neoSEP1新生儿败血症试验),利用网络meta分析类比整合证据,生成个性化治疗排序。 5. **核心目标**:以最高效设计回答最关键科学问题,服务更广泛患者群体。
**平台试验新在哪?** **MAMS如何优化?** **PRACTical有何不同?**
客服
商务合作
小程序
服务号
折叠